MELODY JOHNSON: Open Payments
NPI 1447915269 · WESTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 15 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $446 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $70 |
| Incyte Corporation | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Eisai Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Immunocore Limited | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $17 |
Products named: RYBREVANT, ENHERTU, Lenvima, Vanflyta, KIMMTRAK, VERZENIO, ERLEADA, MONJUVI.
Industry payments across MA — which companies pay providers there.
